News

  • H
    Healthcare
  • L
    LifeSciences
  • S
    Stability & Bio Storage
  • C
    Corporate

Half Year Report 2015

Source BioScience plc today announces its Half Year Report for the six months ended 30 June 2015.

Non-Executive Director Changes

Source BioScience plc announces that Tim Jackson-Smith will join the Board as a Non-Executive Director with immediate effect.

Holdings in Company

The attached TR1 notification relates to the shareholding in Source BioScience plc held by Henderson Global Investors which now stands at 68,303,204 shares, representing 19.78% of the Company’s ordinary share capital

Completion of Acquisition

Source BioScience plc (LSE:SBS), the international laboratory services and products business, announces that its £7.3 million acquisition of Select Pharma Laboratories Ltd (‘Select’) is now complete.

Source BioScience Acquires Select Pharma Laboratories Ltd

Operating in the pharmaceutical, animal health and medical devices sectors, Select is a leading provider of stability storage and testing services, with a strong commercial presence in the UK and overseas.

Result of General Meeting

The Company announces that at its General Meeting held today, shareholders passed the Resolution to approve the acquisition of Select Pharma Laboratories Ltd (the “Acquisition”).

Holdings in Company

The attached TR1 notification relates to the shareholding in Source BioScience plc held by Oryx International Growth Fund Limited which now stands at 50,000,000 shares, representing 15.93% of the Company’s ordinary share capital.